Smartphone mobility tracking strongly predicts COVID-19 outbreaks

Mobility tracking using cell phone data showing greater movement of people is a strong predictor of increased rates of COVID-19, according to new data in CMAJ (Canadian Medical Association Journal).

This study shows that mobility strongly predicts [severe acute respiratory syndrome coronavirus 2] SARS-CoV-2 growth rate up to 3 weeks in the future, and that stringent measures will continue to be necessary through spring 2021 in Canada."

Dr Kevin Brown, Public Health Ontario

Until Canadians are widely vaccinated against SARS-CoV-2, nonpharmaceutical public health interventions such as physical distancing and limiting social contact will be the main population-based means of controlling the spread of the virus.

"Mobility measures capturing human activity through anonymized tracking of smartphones are believed to be reasonable proxies of contact rates outside of one's own home; these measures can provide more timely and reliable sources of information on contact rates compared with time-use surveys or contact tracing," write the authors.

Researchers looked at anonymized smartphone mobility data from March 15, 2020, to March 6, 2021, both nationally and provincially, controlling for date and temperature. They found that a 10% increase in the mobility of Canadians outside their homes correlated with a 25% increase in subsequent SARS-CoV-2 weekly growth rates. They looked at the mobility threshold (the level needed to control the virus) and the mobility gap (the difference between the threshold and actual movement).

"The mobility threshold and mobility gap can be used by public health officials and governments to estimate the level of restrictions needed to control the spread of SARS-CoV-2 and guide, in real-time, the implementation and intensity of nonpharmaceutical public health interventions to control the COVID-19 pandemic," the authors write.

Source:
Journal reference:

Brown, K. A., et al. (2021) The mobility gap: estimating mobility thresholds required to control SARS-CoV-2 in Canada. Canadian Medical Association Journal. doi.org/10.1503/cmaj.210132.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Phase 2 study evaluates safety and efficacy of asunercept in COVID-19 patients